NJ State Employees Deferred Compensation Plan’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
NJ State Employees Deferred Compensation Plan's AMGN Position: Q4 2025 in Review
NJ State Employees Deferred Compensation Plan sold out of Amgen (AMGN) in Q4 2025, closing a stake of 5,880 shares — an estimated $1.66M sold.
NJ State Employees Deferred Compensation Plan first reported a position in AMGN in Q1 2019 and held it in 27 quarters. The position peaked at $2.58M in Q3 2024. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- NJ State Employees Deferred Compensation Plan reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- NJ State Employees Deferred Compensation Plan sold 5,880 Amgen shares in Q4 2025, an estimated $1.66M.
- NJ State Employees Deferred Compensation Plan first reported a position in Amgen in Q1 2019 and held it in 27 quarters.
- NJ State Employees Deferred Compensation Plan's Amgen position peaked at $2.58M in Q3 2024.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.